Literature DB >> 34022689

Cognitive impairment and affective disorder: A rare presentation of cerebellar stroke.

Ece Gok-Dursun1, Ozge Berna Gultekin-Zaim1, Ersin Tan1, Isin Unal-Cevik2.   

Abstract

The awareness of the "Cerebellar Cognitive Affective Syndrome" (CCAS) as a clinical entity is emerging. The CCAS is characterized by impaired executive functions, linguistic skills, visuospatial cognition and personality change. Here we report a 56-year-old, male teacher who developed acute psychomotor retardation, low energy level, infrequent speech, and mild cognitive decline. Two months before admission, he was initially diagnosed as depression, and later misdiagnosed as encephalitis, which misled him to receive high-dose intravenous steroids and antimicrobial drugs. The Brain MRI revealed multiple posterior cerebellar infarcts predominantly at the lobules VII and VIII. The standard neuropsychological tests were unremarkable; however, the CCAS Scale confirmed the diagnosis. The treatment of depression and secondary prevention of stroke was conducted. In cases that present with features of cognitive and affective disorders but with mild voluntary motor or without typical cerebellar features, the role of posterior cerebellar and vermian pathologies should be considered. The CCAS Scale is an appropriate screening tool to detect these patients and provides a framework for evidence-based treatment.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CCAS scale; Cerebellum; Depression; Infarct; Schmahmann syndrome

Mesh:

Year:  2021        PMID: 34022689     DOI: 10.1016/j.clineuro.2021.106690

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  1 in total

1.  Combined Intrinsic Local Functional Connectivity With Multivariate Pattern Analysis to Identify Depressed Essential Tremor.

Authors:  Xueyan Zhang; Li Tao; Huiyue Chen; Xiaoyu Zhang; Hansheng Wang; Wanlin He; Qin Li; Fajin Lv; Tianyou Luo; Jin Luo; Yun Man; Zheng Xiao; Jun Cao; Weidong Fang
Journal:  Front Neurol       Date:  2022-05-10       Impact factor: 4.086

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.